About
Eric De La Fortelle is Head of Business Development and Strategy at the Institute of Molecular and Clinical Ophthalmology Basel. He has held roles across scientific research, biotech, pharma, and venture capital, with experience in project evaluation, innovation management, and startup governance.
Contact· self-published, not guessed
Experience
- Institute of Molecular and Clinical Ophthalmology Basel (IOB)Head of Business Development and Strategycurrent2025 — present
- Cathay HealthManaging Partnercurrent2021 — presentParis - Basel
- Ganymed RoboticsBoard Membercurrent2022 — presentParis, Île-de-France, France
- Health Opportunities GmbHManaging Directorcurrent2014 — presentBasel, Switzerland
- SENSORIONIndependent Board Directorcurrent2015 — presentGreater Montpellier Metropolitan Area
- SENSORIONChairman of the Board of Directors2014 — 2015Greater Montpellier Metropolitan Area
- SENSORIONSupervisory Board Director2012 — 2013Greater Montpellier Metropolitan Area
- Kojin TherapeuticsBoard member representingi Cathay Health2023 — 2025Cambridge, Massachusetts, United States
- IOME BIOBoard Member2021Colmar, Grand Est, France
- Dermala Inc.Board member2020 — 2021San Diego, California, United States
- Siolta TherapeuticsBoard Member2020 — 2021
- Siolta TherapeuticsBoard Observer2019 — 2021San Francisco Bay Area
- Axial Biotherapeutics, Inc.Board Member2019 — 2021Greater Boston
- LiMM TherapeuticsBoard Member2018 — 2021Paris and Lisbon
- A-Mansia Biotech SABoard Director2018 — 2021Bruxelles, Belgium
- DayTwo Ltd.Board Observer2017 — 2021Tel Aviv District, Israel
- Seventure PartnersVenture Partner2014 — 2021Basel, Switzerland
- TargEDysBoard Director2016 — 2020
- MaaT PharmaBoard Director2014 — 2020Lyon, France
- Mint Solutions - MedEyeBoard Director2014 — 2020The Randstad, Netherlands
- BiomX LtdBoard Member2018 — 2019Tel Aviv District, Israel
- BiomX LtdBoard Observer2017 — 2018
- Delenex Therapeutics AGCEO2011 — 2013Schlieren, Zurich area
- F. Hoffmann-La RocheGlobal Head, External Research and Technologies2005 — 2011
- F. Hoffmann-La RocheGlobal Head, Emerging Technologies2008 — 2009
- SGX PharmaceuticalsSenior Director, Business Development2000 — 2004
- MRC Laboratory of Molecular BiologyPost-doctoral scientist1994 — 1998
Skills & more
Valuation33Contract Negotiation47Drug Discovery99Technology Transfer97Business Alliances43Biotechnology32Clinical Trials18Antibodies7Start-ups13Strategic Alliances1Biochemistry4Business Strategy15
+12 more
Corporate DevelopmentVenture CapitalLifesciencesOncologyProtein ChemistryLife SciencesBiopharmaceuticalsDrug DevelopmentStrategyManagementLeadershipBiomarkersFrom Eric's professional profile.
Deals · 5
Ascend Advanced TherapiesSolo GP
via Cathay Health
Moon SurgicalSolo GP
via Cathay Health
TissiumSolo GP
via Cathay Health
Ganymed RoboticsSolo GP
via Cathay Health
Initiate StudioSolo GP
via Cathay Health
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Who is Eric De La Fortelle?
- Eric De La Fortelle is Head of Business Development and Strategy at the Institute of Molecular and Clinical Ophthalmology Basel. He has held roles across scientific research, biotech, pharma, and venture capital, with experience in project evaluation, innovation management, and startup governance.
- Where does Eric De La Fortelle work?
- Eric De La Fortelle is Managing Partner at Cathay Health.
- Where did Eric De La Fortelle go to school?
- Eric De La Fortelle studied at INSEAD (MBA, Finance); Paris-Sud University (Paris XI) (PhD, Biophysics); IFSBM (Institut de Formation Supérieure Biomédicale) (Doctoral Degree, Medical Sciences).
Same school
Also attended INSEAD805
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
.jpg)
+ 799 more
Also attended Paris-Sud University (Paris XI)22
Louis DussartVP, Europe at RTP GlobalXavier LazarusManaging Partner at ElaiaThierry LaugelManaging Partner at Kurma PartnersClement SalqueAssociate at Bioqube VenturesMaria Emilie Kath DanøManaging Partner at PSV Hafnium at PSVNatali Romero BarriosSenior Investment Manager at Andera Partners
+ 16 more
Also attended CentraleSupélec110
Olivier PomelCo-founder & CEO of DatadogAlexis Le-QuocCo-founder & CTO of DatadogPierre GalletInvestor at DaphniSalim HassadPartner at Newfund CapitalBenjamin AuschitzkyScaleup Success Manager at Partech VenturesBruno CrémelGeneral Partner at Partech Ventures
+ 104 more
